Dr. Dimitrios Mathios, MD

Dr. Mathios practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Mathios' NPI, 1568857373, was assigned on March 30, 2015. Dr. Mathios holds Missouri license 2023027385.

Dr. Mathios' primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Mathios also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Mathios' primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Mathios is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Mathios to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mathios practices, 7 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Mathios' primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Mathios is licensed in Missouri.

CMS data shows 224 Medicare services from Dr. Mathios across 11 procedure codes in 2024, for 133 Medicare patients. Medicare paid $51,170 for them.

CMS counts 133 Medicare patients who saw Dr. Mathios in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.77, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mathios' median patient age at 69, with 61% women.

In 2024, Dr. Mathios wrote 84 Medicare Part D claims for 49 patients. 99% of them were for generic drugs. CMS names the drug for 52 of them, across 2 drugs with 11 or more claims each, at $500 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mathios for performance year 2024, reported as part of a group. Dr. Mathios accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mathios as offering telehealth.

Dmand AI links 53 papers to Dr. Mathios, published from 2012 to 2025. 2023 was the busiest year, with 8. The most frequent topics are Cell Line, Tumor, Glioblastoma and Biomarkers, Tumor. Dr. Mathios has published most often in J Neurosurg. Dr. Mathios' most frequent co-authors are Henry Brem, MD, Christopher Mitchell Jackson, MD and Michael Lim, MD.

CMS Open Payments shows 15 general payments to Dr. Mathios from 10 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 52% of the total. Servier Pharmaceuticals LLC paid the most, $1,172.